The “1-3-5 cough test”: comparing the severity of urodynamic stress incontinence with severity measures of subjective perception of stress urinary incontinence

Grigoriadis, Themos; Giannoulis, George; Zacharakis, Dimitrios; Πρωτόπαπας, Αθανάσιος; Cardozo, Linda; Athanasiou, Stavros

doi:10.1007/s00192-015-2808-4

Cited by 10 publications

(6 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…All women were evaluated with urodynamic studies as previously described (including uroflowmetry, filling cystometry, Valsalva leak‐point pressure [VLPP] measurement, and pressure/flow study) by a trained urogynaecologist, using a standardised protocol in accordance with the Good Urodynamic Practices guidelines of the ICS . We evaluated the objective severity of SUI using the ‘1‐3‐5 cough test’ during urodynamics . Urethral hypermobility was defined by a Q‐tip test >30°.…”

Section: Methodsmentioning

confidence: 99%

Efficacy and safety of polydimethylsiloxane injection (Macroplastique^®) for the treatment of female stress urinary incontinence: results of a series of 85 patients with ≥3 years of follow‐up

et al. 2018

View full text Add to dashboard Cite

Objective To assess the long‐term efficacy and safety of polydimethylsiloxane injection (Macroplastique®, Cogentix Medical, Orangeburg, New York, USA) for the treatment of female stress urinary incontinence (SUI), with a minimum follow‐up of 3 years. Patients and Methods This is an observational analytical prospective cohort study conducted in a single uro‐gynaecological unit. All consecutive women with urodynamically confirmed pure SUI treated with the Macroplastique procedure, were included. Data regarding patient outcomes (International Consultation on Incontinence Questionnaire–Short Form, Patient Global Impression of Improvement, and patient satisfaction scores), objective cure rates, and adverse events were collected during follow‐up. Uni‐ and multivariable analyses were performed to investigate outcomes. Multiple logistic regression was performed to identify factors involved in the risk of failure of the procedures or recurrence of SUI. Results In all, 85 women had the Macroplastique procedure. At the 3‐year follow‐up, all 85 (100%) patients were available for the evaluation. We did not find any significant change in the surgical outcomes during this time. At 3 years after surgery, 42 of 85 patients (49%) declared themselves cured (P = 0.67). Similarly, at the 3‐year evaluation, 40 of 85 patients (47%) were objectively cured. There was no significant deterioration of objective cure rates over time (P = 0.3). A history of radical pelvic surgery and a low surgeon's skill were significantly associated with the risk of failure of Macroplastique. The multivariate analysis confirmed these findings; a previous history of radical pelvic surgery and a low surgeon's skill independently predicted the subjective and objective failure of Macroplastique. Conclusions The 3‐year results of this study showed that Macroplastique could be an acceptable alternative for the treatment of SUI with stable results over time and a negligible complication rate.

show abstract

Section: Methodsmentioning

confidence: 99%

Efficacy and safety of polydimethylsiloxane injection (Macroplastique^®) for the treatment of female stress urinary incontinence: results of a series of 85 patients with ≥3 years of follow‐up

et al. 2018

View full text Add to dashboard Cite

show abstract

“…In many reports that used a CST there was no mention of the number of times the patient was asked to cough (Figures and ). There is some evidence that, during UDS, multiple coughs are more likely to elicit leakage as was demonstrated during a “1‐3‐5” cough test . The patient initially coughs once and if no SUI is noted then coughs three times and again if no SUI is noted then coughs five times.…”

Section: Methodsmentioning

confidence: 98%

“…There is some evidence that, during UDS, multiple coughs are more likely to elicit leakage as was demonstrated during a "1-3-5" cough test. 30 The patient initially coughs once and if no SUI is noted then coughs three times and again if no SUI is noted then coughs five times. The "severity" of SUI was graded based on the occurrence of SUI after fewer coughs (more severe) versus many coughs (more mild).…”

Section: Number/forcefulness Of Coughsmentioning

confidence: 99%

ICS Educational Module: Cough stress test in the evaluation of female urinary incontinence: Introducing the ICS‐Uniform Cough Stress Test

Guralnick

Fritel

Tarcan

et al. 2018

Neurourology and Urodynamics

View full text Add to dashboard Cite

show abstract

“…18 In addition, they underwent a 1-hour pad test following the standardized protocol as described by the ICS and a multichannel urodynamic study. 19,20 One month after the second injection session (T1), the participants completed the ICIQ-FLUTS, the KHQ, and the Patient Global Impression Scale of Improvement (PGI-I) questionnaires. The PGI-I is a 7-point transition scale of a single question used to rate patient responses regarding their SUI symptoms as compared with how it was before treatment on a scale from 1 (very much better) to 7 (very much worse).…”

Section: Study Protocolmentioning

confidence: 99%

Platelet-Rich Plasma for the Treatment of Stress Urinary Incontinence—A Randomized Trial

Grigoriadis,

Kalantzis,

Zacharakis

et al. 2023

UROGC

Self Cite

View full text Add to dashboard Cite

Importance Urinary incontinence affects millions of women worldwide. Objective The aim of the current study was to evaluate the efficacy and safety of periurethral platelet-rich plasma (PRP) injections in women with stress urinary incontinence (SUI). Study Design This was a single-center, double-blind, randomized sham-controlled trial. Fifty participants with SUI and urodynamic stress incontinence were randomized in 2 equally sized groups. Women in the PRP group received 2 PRP injections at 3 levels of the urethra at 4- to 6-week intervals. Women in the sham group were injected with sodium chloride 0.9%. At baseline, participants underwent urodynamic studies and a 1-hour pad test and completed the International Consultation on Incontinence Questionnaire—Female Lower Urinary Tract Symptoms (ICIQ-FLUTS), the Patient Global Impression Scale of Improvement, and the King's Health Questionnaire. At follow-up visits (1, 3, and 6 months), women underwent the 1-hour pad test and completed the King's Health Questionnaire and the ICIQ-FLUTS. Primary outcome was the subjective evaluation as indicated by the response to question 11a of the ICIQ-FLUTS questionnaire. Secondary outcomes included scores of questionnaires and urine loss assessed on the 1-hour pad test. The level of discomfort during injections and any adverse events were also evaluated. Results During follow-up, the mean score of the 11a question decreased significantly in the PRP group compared with sham. Subjective cure was significantly higher in the PRP group (32% vs 4%, P < 0.001). A significant reduction of urine loss assessed on the 1-hour pad test was observed in the PRP group compared with the sham group at 6-month follow-up. No adverse events were observed. Conclusions Periurethral PRP injections were superior to sham injections in improving SUI symptoms with an excellent safety profile.

show abstract

The “1-3-5 cough test”: comparing the severity of urodynamic stress incontinence with severity measures of subjective perception of stress urinary incontinence

Abstract: Severity of USI, as defined by the "1-3-5 cough test", was associated with the severity of subjective measures of SUI. This test may be a useful tool for the objective interpretation of patients with SUI who undergo urodynamics.

Cited by 10 publications

References 17 publications

Efficacy and safety of polydimethylsiloxane injection (Macroplastique^®) for the treatment of female stress urinary incontinence: results of a series of 85 patients with ≥3 years of follow‐up

Efficacy and safety of polydimethylsiloxane injection (Macroplastique^®) for the treatment of female stress urinary incontinence: results of a series of 85 patients with ≥3 years of follow‐up

ICS Educational Module: Cough stress test in the evaluation of female urinary incontinence: Introducing the ICS‐Uniform Cough Stress Test

Platelet-Rich Plasma for the Treatment of Stress Urinary Incontinence—A Randomized Trial

Contact Info

Product

Resources

About

The “1-3-5 cough test”: comparing the severity of urodynamic stress incontinence with severity measures of subjective perception of stress urinary incontinence

Abstract: Severity of USI, as defined by the "1-3-5 cough test", was associated with the severity of subjective measures of SUI. This test may be a useful tool for the objective interpretation of patients with SUI who undergo urodynamics.

Cited by 10 publications

References 17 publications

Efficacy and safety of polydimethylsiloxane injection (Macroplastique®) for the treatment of female stress urinary incontinence: results of a series of 85 patients with ≥3 years of follow‐up

Efficacy and safety of polydimethylsiloxane injection (Macroplastique®) for the treatment of female stress urinary incontinence: results of a series of 85 patients with ≥3 years of follow‐up

ICS Educational Module: Cough stress test in the evaluation of female urinary incontinence: Introducing the ICS‐Uniform Cough Stress Test

Platelet-Rich Plasma for the Treatment of Stress Urinary Incontinence—A Randomized Trial

Contact Info

Product

Resources

About

Efficacy and safety of polydimethylsiloxane injection (Macroplastique^®) for the treatment of female stress urinary incontinence: results of a series of 85 patients with ≥3 years of follow‐up

Efficacy and safety of polydimethylsiloxane injection (Macroplastique^®) for the treatment of female stress urinary incontinence: results of a series of 85 patients with ≥3 years of follow‐up